SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as the community debates its recent partnership with Anduril to develop a dual-use autonomous aircraft platform, with discussions split between bullish excitement over defense potential and skepticism regarding commercial scaling hurdles. Investors remain focused on the company's progress toward FAA certification and the elusive transition to horizontal flight as critical milestones for the stock's future.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently seeing heightened volatility and intense community debate as the stock experiences a significant pullback from recent highs, fueled by broader space sector turbulence and shifts in institutional sentiment. While bears argue the company is overvalued and lacking near-term profitability, many investors remain bullish on the long-term potential of the Neutron launch vehicle and the company's vertically integrated space infrastructure strategy.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense trading volume and market interest after securing $2.8 billion in new multi-year AI cloud contracts and raising its year-end ARR guidance, signaling strong demand for its expanded infrastructure capacity. While bullish sentiment is fueled by these wins and a significant cash position, the community remains divided, with debates persisting between those expecting a major AI infrastructure recovery and others skeptical of potential share dilution and execution risks.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital Inc. ($NUAI) is gaining strong momentum as the community focuses on its role in AI infrastructure, particularly its potential in power-intensive data center development. Investors are actively discussing upcoming index inclusion, expectations for tenant lease news, and the company's strategic advantage in providing off-grid, behind-the-meter energy solutions for hyperscalers.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as the market evaluates its strategic position following new U.S. executive orders that limit reliance on foreign-sourced critical minerals and prioritize domestic supply chain security. While the community is actively debating the company's leadership transition and the impact of recent government funding, sentiment remains divided between those betting on the stock as a long-term play on national security and those expressing frustration over short-term price volatility.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is experiencing significant market interest as investors rotate into high-growth consumer brands, fueled by strategic expansions into the haircare market and recent analyst price target upgrades. Community sentiment remains polarized between long-term bulls highlighting strong brand loyalty and fundamentals, and skeptical bears focused on technical price pressure and macroeconomic headwinds.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery shareholders are preparing for a pivotal vote on the proposed $110 billion merger with Paramount Skydance, with market sentiment heavily focused on the significant cash premium offered in the deal. Investors are closely monitoring potential regulatory hurdles and the contentious debate surrounding the CEO's executive compensation package, as the merger faces ongoing scrutiny from industry figures and lawmakers concerned about media consolidation.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings Ltd. is trending due to significant investor interest surrounding a definitive agreement to acquire a pharmaceutical company for over one billion dollars, fueling speculation about a potential short squeeze. While bulls are aggressively pushing the stock higher, citing the low float and bullish technical setups, many community members remain skeptical, labeling the rapid price action as a pump-and-dump scheme and warning of historical volatility typical of similar small-cap listings.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors weigh recent institutional moves and executive leadership changes against the upcoming expiration of the TDAPA reimbursement period for DefenCath. The community is actively debating the potential impact of pending kidney care legislation and speculating on future acquisition or merger possibilities while tracking ongoing adoption rates.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is facing significant selling pressure as investors react to a year-over-year revenue decline, despite the company highlighting an 88% surge in higher-margin systems integration revenue. The community is actively debating whether the stock represents a deep-value buying opportunity driven by AI infrastructure demand or a high-risk gamble due to intense customer concentration with Dell and ongoing insider selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?

The consensus price target hints at a 61.5% upside potential for Nuvectis Pharma (NVCT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now?

Does Nuvectis Pharma, Inc. (NVCT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up, Dow futures gain 100+ points. Concentrix Corp (CNXC) shares down 24% after weak Q2 results and lowered FY26 guidance. Other stocks also decline in pre-market trading.read more...

What Makes Nuvectis Pharma (NVCT) a New Buy Stock

Nuvectis Pharma (NVCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Nuvectis Pharma Jumps 20% To 52-Week High  Here's Why NVCT Stock Is Trending

NVCT stock jumped after Nuvectis expanded its pipeline through a licensing deal with Haisco.read more...

Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet

The mean of analysts' price targets for Nuvectis Pharma (NVCT) points to a 57% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 62.5% in Nuvectis Pharma (NVCT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Nuvectis Pharma (NASDAQ:NVCT) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04...

Nuvectis Pharma (NVCT) Projected to Post Earnings on Tuesday

Nuvectis Pharma (NASDAQ:NVCT) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-nuvectis-pharma-inc-stock...

Nuvectis Pharma, Inc. $NVCT Shares Acquired by Iridian Asset Management LLC CT

Iridian Asset Management LLC CT increased its holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) by 44.5% during the fourth quarter, according to its most recent filing with the Securities...

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Nuvectis Pharma Inc

Bearish Sentiment

Yes, frequently

Yes, occasionally

Rarely

Never

Have you ever invested in an ETF without fully assessing how it works or the associated risks? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

Have you ever invested in an ETF without fully assessing how it works or the associated risks? 
 
*Sponsored by Calamos and S&P Global

Current Price	$18.07
Prev Close	$19.14
Open	$19.12
Dividend Yield	0.00%
50-Day Moving Average	$14.38
Beta	0.96
Avg. Volume	430,971.65
PE Ratio	-15.01

52-Week High	$29.28
52-Week Low	$5.55
Market Capitalization	$603.4M
EPS (Annual)	-$1.32
Price to Book	35.70
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

NVCTNuvectis Pharma Inc

Latest NVCT News